MINNEAPOLIS, June 15 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI - News) announced their first approval for the Company's next-generation Urgent® PC Neuromodulation System. The Therapeutic Products Directorate of Health Canada approved the Company's amended license to sell the Urgent PC in Canada. Regulatory clearances from European and US agencies are currently pending.
